StonvexLoading…
StonvexStonvexStonvexCore line items from AME's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.93B | $7.40B | $5.40B | $3.51B |
Operating Income | $514.94M | $1.91B | $1.40B | $916.46M |
Net Income | $399.36M | $1.48B | $1.08B | $710.13M |
EPS (Diluted) | $1.74 | $6.40 | $4.67 | $3.07 |
Total Assets | $16.31B | $16.07B | $16.18B | $15.27B |
Total Liabilities | $5.39B | $5.44B | $5.66B | $4.88B |
Cash & Equivalents | $481.25M | $457.95M | $439.24M | $619.71M |
Free Cash Flow OCF − CapEx | $426.05M | $1.67B | $1.14B | $724.30M |
Shares Outstanding | 229.84M | 229.00M | 231.56M | 231.51M |